Literature DB >> 28960320

CMV and natural killer cells: shaping the response to vaccination.

Martin R Goodier1, Stipan Jonjić2, Eleanor M Riley1, Vanda Juranić Lisnić2.   

Abstract

Cytomegaloviruses (CMVs) are highly prevalent, persistent human pathogens that not only evade but also shape our immune responses. Natural killer (NK) cells play an important role in the control of CMV and CMVs have in turn developed a plethora of immunoevasion mechanisms targeting NK cells. This complex interplay can leave a long-lasting imprint on the immune system in general and affect responses toward other pathogens and vaccines. This review aims to provide an overview of NK cell biology and development, the manipulation of NK cells by CMVs and the potential impact of these evasion strategies on responses to vaccination.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CMV; HCMV; Immune evasion; NK cells; Vaccination

Mesh:

Substances:

Year:  2017        PMID: 28960320     DOI: 10.1002/eji.201646762

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  31 in total

1.  The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.

Authors:  Vu Thuy Khanh Le-Trilling; Ofer Mandelboim; Liat Dassa; Einat Seidel; Esther Oiknine-Djian; Rachel Yamin; Dana G Wolf
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

2.  Endoplasmic Reticulum (ER) Reorganization and Intracellular Retention of CD58 Are Functionally Independent Properties of the Human Cytomegalovirus ER-Resident Glycoprotein UL148.

Authors:  Christopher C Nguyen; Anthony J Domma; Hongbo Zhang; Jeremy P Kamil
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

3.  Expression of the Pseudorabies Virus gB Glycoprotein Triggers NK Cell Cytotoxicity and Increases Binding of the Activating NK Cell Receptor PILRβ.

Authors:  Steffi De Pelsmaeker; Evelien Dierick; Barbara Klupp; Thomas C Mettenleiter; Claudia Cantoni; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 4.  Recasting Human Vδ1 Lymphocytes in an Adaptive Role.

Authors:  Martin S Davey; Carrie R Willcox; Alfie T Baker; Stuart Hunter; Benjamin E Willcox
Journal:  Trends Immunol       Date:  2018-04-18       Impact factor: 16.687

5.  The convergent epidemiology of tuberculosis and human cytomegalovirus infection.

Authors:  Frank Cobelens; Nico Nagelkerke; Helen Fletcher
Journal:  F1000Res       Date:  2018-03-06

Review 6.  Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine.

Authors:  Silvia Capellino; Maren Claus; Carsten Watzl
Journal:  Cell Mol Immunol       Date:  2020-06-05       Impact factor: 11.530

7.  In vivo Downregulation of MHC Class I Molecules by HCMV Occurs During All Phases of Viral Replication but Is Not Always Complete.

Authors:  Florin Gabor; Gerhard Jahn; Daniel D Sedmak; Christian Sinzger
Journal:  Front Cell Infect Microbiol       Date:  2020-06-12       Impact factor: 5.293

Review 8.  HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.

Authors:  Burcu Duygu; Timo I Olieslagers; Mathijs Groeneweg; Christina E M Voorter; Lotte Wieten
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

Review 9.  Vaccinating for natural killer cell effector functions.

Authors:  Helen R Wagstaffe; Jason P Mooney; Eleanor M Riley; Martin R Goodier
Journal:  Clin Transl Immunology       Date:  2018-01-31

Review 10.  Variations in killer-cell immunoglobulin-like receptor and human leukocyte antigen genes and immunity to malaria.

Authors:  Stephen Tukwasibwe; Annettee Nakimuli; James Traherne; Olympe Chazara; Jyothi Jayaraman; John Trowsdale; Ashley Moffett; Prasanna Jagannathan; Philip J Rosenthal; Stephen Cose; Francesco Colucci
Journal:  Cell Mol Immunol       Date:  2020-06-15       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.